LifeStance Health (LFST) Cash & Current Investments (2020 - 2026)

LifeStance Health (LFST) has 7 years of Cash & Current Investments data on file, last reported at $76.9 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $76.9 million, down 43.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $76.9 million (down 43.09% YoY), and the FY2025 annual result was $175.5 million, up 43.68% from the prior year.
• Cash & Current Investments slipped to $76.9 million in Q1 2026 per LFST's latest filing, from $175.5 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $175.5 million in Q4 2025 and troughed at $34.4 million in Q3 2023.
• A 5-year average of $105.0 million and a median of $113.0 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments slumped 71.04% in 2024, then surged 272.27% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $113.0 million in 2022, then plunged by 37.52% to $70.6 million in 2023, then jumped by 72.96% to $122.2 million in 2024, then jumped by 43.68% to $175.5 million in 2025, then sank by 56.17% to $76.9 million in 2026.
• Business Quant data shows LFST's Cash & Current Investments at $76.9 million in Q1 2026, $175.5 million in Q4 2025, and $141.8 million in Q3 2025.